Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcus aureus | 20 | 2019 | 1451 | 1.340 |
Why?
|
Anti-Bacterial Agents | 34 | 2021 | 7181 | 1.110 |
Why?
|
Oxazolidinones | 10 | 2007 | 96 | 1.050 |
Why?
|
Acetamides | 10 | 2007 | 249 | 0.960 |
Why?
|
Vancomycin Resistance | 10 | 2007 | 128 | 0.900 |
Why?
|
Drug Resistance, Bacterial | 11 | 2009 | 1035 | 0.890 |
Why?
|
Azithromycin | 2 | 2021 | 196 | 0.850 |
Why?
|
Vancomycin | 15 | 2018 | 501 | 0.850 |
Why?
|
Staphylococcal Infections | 15 | 2017 | 1400 | 0.800 |
Why?
|
Gram-Positive Bacterial Infections | 9 | 2011 | 341 | 0.780 |
Why?
|
Hydroxychloroquine | 2 | 2021 | 412 | 0.710 |
Why?
|
Abscess | 3 | 2016 | 607 | 0.580 |
Why?
|
RNA, Ribosomal, 23S | 7 | 2007 | 53 | 0.560 |
Why?
|
Trimethoprim | 1 | 2016 | 91 | 0.550 |
Why?
|
Sulfadoxine | 1 | 2016 | 49 | 0.550 |
Why?
|
Long QT Syndrome | 1 | 2020 | 453 | 0.540 |
Why?
|
Skin Diseases, Bacterial | 1 | 2016 | 66 | 0.520 |
Why?
|
Bacteriological Techniques | 4 | 2017 | 277 | 0.510 |
Why?
|
Methicillin Resistance | 10 | 2006 | 198 | 0.500 |
Why?
|
Bacteremia | 6 | 2019 | 962 | 0.500 |
Why?
|
Enterococcus faecium | 7 | 2003 | 102 | 0.490 |
Why?
|
Enterococcus | 6 | 2004 | 157 | 0.480 |
Why?
|
Candida | 2 | 2017 | 172 | 0.450 |
Why?
|
Antibiotic Prophylaxis | 4 | 2019 | 639 | 0.440 |
Why?
|
Staphylococcus | 3 | 2014 | 155 | 0.420 |
Why?
|
Gemella | 1 | 2011 | 5 | 0.410 |
Why?
|
Prosthesis-Related Infections | 4 | 2018 | 538 | 0.400 |
Why?
|
Blood | 3 | 2010 | 598 | 0.400 |
Why?
|
Drainage | 1 | 2016 | 1142 | 0.360 |
Why?
|
Microbial Sensitivity Tests | 21 | 2014 | 1877 | 0.350 |
Why?
|
Anti-Infective Agents | 7 | 2018 | 972 | 0.350 |
Why?
|
Penicillins | 5 | 2014 | 380 | 0.330 |
Why?
|
Bacterial Proteins | 9 | 2010 | 3848 | 0.320 |
Why?
|
beta-Lactamases | 5 | 2019 | 306 | 0.320 |
Why?
|
Sweet Syndrome | 1 | 2008 | 47 | 0.310 |
Why?
|
Sinusitis | 1 | 2017 | 923 | 0.310 |
Why?
|
Drug Prescriptions | 1 | 2017 | 1637 | 0.300 |
Why?
|
Mycobacterium | 1 | 2009 | 249 | 0.300 |
Why?
|
Cross Infection | 9 | 2017 | 1416 | 0.300 |
Why?
|
Genes, rRNA | 2 | 2004 | 70 | 0.290 |
Why?
|
Enterococcus faecalis | 5 | 2004 | 251 | 0.290 |
Why?
|
Fluoroquinolones | 5 | 2021 | 310 | 0.270 |
Why?
|
Equipment Contamination | 2 | 2017 | 185 | 0.270 |
Why?
|
Syphilis | 1 | 2008 | 227 | 0.260 |
Why?
|
Methicillin | 2 | 2003 | 59 | 0.250 |
Why?
|
Osteoarthritis | 1 | 2011 | 1036 | 0.230 |
Why?
|
Mastitis | 2 | 2013 | 41 | 0.220 |
Why?
|
Trans-Activators | 2 | 2003 | 2924 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Clostridium Infections | 2 | 2019 | 548 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2017 | 687 | 0.200 |
Why?
|
Cefazolin | 2 | 2019 | 96 | 0.200 |
Why?
|
Pacemaker, Artificial | 2 | 2018 | 816 | 0.200 |
Why?
|
DNA, Ribosomal | 3 | 2011 | 290 | 0.200 |
Why?
|
Drug Resistance, Microbial | 6 | 2001 | 862 | 0.200 |
Why?
|
Sterilization | 2 | 2017 | 133 | 0.190 |
Why?
|
Candidiasis | 2 | 2017 | 366 | 0.190 |
Why?
|
HIV | 1 | 2008 | 1604 | 0.180 |
Why?
|
Gram-Negative Bacteria | 2 | 2004 | 270 | 0.180 |
Why?
|
Nafcillin | 1 | 2019 | 25 | 0.170 |
Why?
|
Surgical Wound Infection | 2 | 2019 | 1540 | 0.170 |
Why?
|
Genes, Bacterial | 5 | 2004 | 1079 | 0.160 |
Why?
|
o-Phthalaldehyde | 1 | 2017 | 16 | 0.150 |
Why?
|
Ethylene Oxide | 1 | 2017 | 27 | 0.150 |
Why?
|
Duodenoscopy | 1 | 2017 | 52 | 0.150 |
Why?
|
Equipment Reuse | 1 | 2017 | 41 | 0.150 |
Why?
|
Diabetic Foot | 1 | 2021 | 355 | 0.150 |
Why?
|
Duodenoscopes | 1 | 2017 | 44 | 0.150 |
Why?
|
Defibrillators, Implantable | 2 | 2017 | 1440 | 0.150 |
Why?
|
Aortic Aneurysm | 1 | 2021 | 643 | 0.140 |
Why?
|
beta-Lactams | 2 | 2018 | 160 | 0.140 |
Why?
|
DNA, Bacterial | 4 | 2011 | 1465 | 0.140 |
Why?
|
Streptococcus pneumoniae | 2 | 2004 | 714 | 0.140 |
Why?
|
Daptomycin | 2 | 2007 | 73 | 0.140 |
Why?
|
Disinfectants | 1 | 2017 | 116 | 0.140 |
Why?
|
Microbiological Techniques | 1 | 2017 | 102 | 0.140 |
Why?
|
Pneumonia, Mycoplasma | 1 | 2015 | 50 | 0.130 |
Why?
|
Sequence Analysis, DNA | 6 | 2011 | 4803 | 0.130 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6489 | 0.130 |
Why?
|
Disinfection | 1 | 2017 | 191 | 0.130 |
Why?
|
Mucositis | 1 | 2015 | 101 | 0.120 |
Why?
|
Enterobacter | 2 | 2005 | 46 | 0.120 |
Why?
|
Neutropenia | 1 | 2019 | 895 | 0.120 |
Why?
|
Immunocompromised Host | 1 | 2019 | 847 | 0.120 |
Why?
|
Pneumonia, Bacterial | 1 | 2017 | 316 | 0.120 |
Why?
|
Drug Combinations | 2 | 2018 | 1959 | 0.120 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 454 | 0.120 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 5 | 2006 | 143 | 0.120 |
Why?
|
RNA, Bacterial | 2 | 2007 | 390 | 0.120 |
Why?
|
Catheters, Indwelling | 1 | 1996 | 426 | 0.120 |
Why?
|
Teicoplanin | 1 | 1993 | 27 | 0.120 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2018 | 329 | 0.120 |
Why?
|
Antimalarials | 1 | 2020 | 905 | 0.110 |
Why?
|
Humans | 60 | 2021 | 744343 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1071 | 0.110 |
Why?
|
Digestive System Surgical Procedures | 1 | 2018 | 576 | 0.110 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 567 | 0.110 |
Why?
|
Catheterization, Central Venous | 1 | 1996 | 514 | 0.100 |
Why?
|
beta-Lactam Resistance | 4 | 2014 | 79 | 0.100 |
Why?
|
Disease Outbreaks | 2 | 2017 | 1772 | 0.100 |
Why?
|
Klebsiella Infections | 2 | 2010 | 138 | 0.100 |
Why?
|
Exanthema | 1 | 2015 | 501 | 0.100 |
Why?
|
Penicillin-Binding Proteins | 2 | 2010 | 137 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2018 | 961 | 0.090 |
Why?
|
Virus Diseases | 1 | 2017 | 711 | 0.090 |
Why?
|
Klebsiella | 1 | 2010 | 48 | 0.090 |
Why?
|
Recurrence | 3 | 2017 | 8340 | 0.090 |
Why?
|
Middle Aged | 24 | 2020 | 213383 | 0.090 |
Why?
|
Sulbactam | 2 | 2018 | 26 | 0.090 |
Why?
|
Postpartum Period | 2 | 2013 | 1086 | 0.090 |
Why?
|
Ampicillin | 2 | 2018 | 139 | 0.090 |
Why?
|
Acute Disease | 2 | 2017 | 7149 | 0.080 |
Why?
|
Male | 30 | 2020 | 350118 | 0.080 |
Why?
|
Acute Kidney Injury | 2 | 2019 | 1972 | 0.080 |
Why?
|
Mutation | 5 | 2007 | 29786 | 0.080 |
Why?
|
Oxacillin | 2 | 2014 | 42 | 0.080 |
Why?
|
Staphylococcal Skin Infections | 1 | 2009 | 75 | 0.080 |
Why?
|
Debridement | 1 | 2011 | 492 | 0.080 |
Why?
|
Virginiamycin | 2 | 1998 | 11 | 0.080 |
Why?
|
Molecular Sequence Data | 6 | 2002 | 18111 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2266 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1401 | 0.080 |
Why?
|
Treponema pallidum | 1 | 2008 | 40 | 0.080 |
Why?
|
Mycobacterium Infections | 1 | 2009 | 119 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2011 | 954 | 0.080 |
Why?
|
Soft Tissue Infections | 1 | 2009 | 155 | 0.080 |
Why?
|
Hospitals, Veterans | 3 | 2018 | 404 | 0.070 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1199 | 0.070 |
Why?
|
Hospitals, Urban | 1 | 2009 | 499 | 0.070 |
Why?
|
Risk Factors | 13 | 2018 | 72290 | 0.070 |
Why?
|
Injections, Intramuscular | 1 | 2008 | 552 | 0.070 |
Why?
|
Operon | 1 | 2007 | 363 | 0.070 |
Why?
|
Glycopeptides | 2 | 2001 | 224 | 0.070 |
Why?
|
Escherichia coli | 3 | 2004 | 4217 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 326 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1832 | 0.070 |
Why?
|
Hemolysin Proteins | 2 | 2006 | 113 | 0.070 |
Why?
|
Cohort Studies | 6 | 2020 | 40561 | 0.070 |
Why?
|
Hospitalization | 3 | 2020 | 10262 | 0.070 |
Why?
|
Gene Deletion | 2 | 2004 | 2751 | 0.070 |
Why?
|
Carrier State | 1 | 2009 | 518 | 0.070 |
Why?
|
HIV Infections | 2 | 2009 | 16718 | 0.060 |
Why?
|
Female | 25 | 2020 | 380194 | 0.060 |
Why?
|
Aged | 17 | 2020 | 163280 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12959 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2004 | 30 | 0.060 |
Why?
|
Cephalosporin Resistance | 1 | 2004 | 17 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2019 | 3523 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8642 | 0.060 |
Why?
|
Blotting, Southern | 1 | 2004 | 803 | 0.060 |
Why?
|
Piperacillin | 1 | 2003 | 41 | 0.060 |
Why?
|
Escherichia coli Infections | 3 | 2004 | 532 | 0.060 |
Why?
|
Ceftazidime | 1 | 2003 | 69 | 0.060 |
Why?
|
Penicillanic Acid | 1 | 2003 | 45 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7279 | 0.060 |
Why?
|
Chromosomes, Bacterial | 1 | 2004 | 282 | 0.060 |
Why?
|
Leukapheresis | 1 | 2003 | 131 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2019 | 77449 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5751 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2002 | 13815 | 0.050 |
Why?
|
Ceftriaxone | 1 | 2003 | 168 | 0.050 |
Why?
|
Case-Control Studies | 9 | 2018 | 21746 | 0.050 |
Why?
|
Klebsiella pneumoniae | 1 | 2004 | 251 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 2 | 1999 | 2839 | 0.050 |
Why?
|
Erythromycin | 2 | 2003 | 120 | 0.050 |
Why?
|
Penicillin Resistance | 2 | 2004 | 84 | 0.050 |
Why?
|
Hexosyltransferases | 1 | 2001 | 53 | 0.050 |
Why?
|
Polymerase Chain Reaction | 4 | 2005 | 6171 | 0.050 |
Why?
|
Peptidyl Transferases | 1 | 2001 | 54 | 0.050 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2004 | 232 | 0.050 |
Why?
|
Osteomyelitis | 1 | 2006 | 402 | 0.050 |
Why?
|
Point Mutation | 2 | 2004 | 1623 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2003 | 315 | 0.050 |
Why?
|
Molecular Epidemiology | 2 | 2004 | 468 | 0.050 |
Why?
|
Mass Screening | 1 | 2017 | 5255 | 0.050 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2001 | 192 | 0.050 |
Why?
|
Enterobacteriaceae Infections | 1 | 2003 | 187 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2002 | 768 | 0.050 |
Why?
|
Serratia marcescens | 1 | 2000 | 45 | 0.050 |
Why?
|
Primary Health Care | 1 | 2017 | 4558 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5442 | 0.050 |
Why?
|
Methyltransferases | 1 | 2003 | 367 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.050 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1584 | 0.050 |
Why?
|
Administration, Oral | 1 | 2008 | 3913 | 0.050 |
Why?
|
Hemolysis | 1 | 2002 | 420 | 0.050 |
Why?
|
Laboratories, Hospital | 1 | 2001 | 194 | 0.040 |
Why?
|
Conjugation, Genetic | 2 | 2005 | 126 | 0.040 |
Why?
|
Carbapenems | 1 | 2000 | 118 | 0.040 |
Why?
|
Gene Dosage | 1 | 2004 | 1252 | 0.040 |
Why?
|
Peptide Synthases | 1 | 1999 | 80 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23338 | 0.040 |
Why?
|
Oligonucleotides, Antisense | 1 | 2001 | 433 | 0.040 |
Why?
|
Base Sequence | 3 | 2002 | 12797 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2019 | 63114 | 0.040 |
Why?
|
Fetal Blood | 1 | 2004 | 1318 | 0.040 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2018 | 165 | 0.040 |
Why?
|
Metronidazole | 1 | 2018 | 217 | 0.040 |
Why?
|
Logistic Models | 4 | 2019 | 13408 | 0.040 |
Why?
|
United States | 8 | 2021 | 69872 | 0.040 |
Why?
|
Latex Fixation Tests | 2 | 2010 | 32 | 0.040 |
Why?
|
Young Adult | 4 | 2017 | 56430 | 0.040 |
Why?
|
Gases | 1 | 2017 | 197 | 0.040 |
Why?
|
Open Reading Frames | 1 | 1999 | 810 | 0.030 |
Why?
|
Adult | 10 | 2019 | 214055 | 0.030 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 613 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2004 | 1620 | 0.030 |
Why?
|
Oxazoles | 1 | 1996 | 189 | 0.030 |
Why?
|
DNA Primers | 1 | 1999 | 2892 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1999 | 2256 | 0.030 |
Why?
|
Cefoxitin | 1 | 2014 | 36 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12245 | 0.030 |
Why?
|
Creatinine | 1 | 2019 | 1919 | 0.030 |
Why?
|
Cephalosporins | 1 | 2014 | 204 | 0.030 |
Why?
|
Phenotype | 3 | 2004 | 16365 | 0.030 |
Why?
|
Diarrhea | 1 | 2019 | 1348 | 0.030 |
Why?
|
DNA Probes | 1 | 1993 | 560 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2017 | 642 | 0.030 |
Why?
|
Quality Improvement | 2 | 2018 | 3749 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 1993 | 1375 | 0.030 |
Why?
|
Assisted Circulation | 1 | 1971 | 103 | 0.020 |
Why?
|
Device Removal | 1 | 2016 | 656 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1999 | 4740 | 0.020 |
Why?
|
Culture Media | 2 | 2004 | 908 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2018 | 57776 | 0.020 |
Why?
|
Perioperative Care | 1 | 2018 | 1002 | 0.020 |
Why?
|
Time Factors | 4 | 2018 | 40075 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2003 | 3386 | 0.020 |
Why?
|
Intensive Care Units | 2 | 2001 | 3679 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2015 | 1265 | 0.020 |
Why?
|
Infection Control | 1 | 1996 | 966 | 0.020 |
Why?
|
Boston | 2 | 2018 | 9313 | 0.020 |
Why?
|
Algorithms | 1 | 2009 | 13881 | 0.020 |
Why?
|
Health Services | 1 | 2013 | 758 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12354 | 0.020 |
Why?
|
Perineum | 1 | 2009 | 211 | 0.020 |
Why?
|
Novobiocin | 1 | 2007 | 35 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3749 | 0.020 |
Why?
|
Decision Making | 1 | 2001 | 3887 | 0.020 |
Why?
|
Nasal Cavity | 1 | 2009 | 313 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3610 | 0.020 |
Why?
|
Aminoacyltransferases | 1 | 2007 | 51 | 0.020 |
Why?
|
Genotype | 1 | 2001 | 12951 | 0.020 |
Why?
|
Bacteriolysis | 1 | 2006 | 51 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 1971 | 688 | 0.020 |
Why?
|
Genetic Variation | 1 | 2000 | 6544 | 0.020 |
Why?
|
Length of Stay | 1 | 2018 | 6309 | 0.020 |
Why?
|
Isoelectric Focusing | 1 | 2004 | 181 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2018 | 5317 | 0.020 |
Why?
|
Patient Readmission | 1 | 2018 | 3114 | 0.010 |
Why?
|
Prospective Studies | 4 | 2017 | 53288 | 0.010 |
Why?
|
Incidence | 2 | 2018 | 20947 | 0.010 |
Why?
|
Risk-Taking | 1 | 2009 | 986 | 0.010 |
Why?
|
Biopsy | 1 | 2015 | 6756 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1859 | 0.010 |
Why?
|
Cell Culture Techniques | 2 | 2003 | 1678 | 0.010 |
Why?
|
Aorta | 1 | 1971 | 2061 | 0.010 |
Why?
|
Enterobacteriaceae | 1 | 2004 | 169 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 933 | 0.010 |
Why?
|
Breast | 1 | 2011 | 1969 | 0.010 |
Why?
|
Muramoylpentapeptide Carboxypeptidase | 1 | 2001 | 26 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1791 | 0.010 |
Why?
|
Carbon-Oxygen Ligases | 1 | 2001 | 4 | 0.010 |
Why?
|
Outpatients | 1 | 2009 | 1486 | 0.010 |
Why?
|
Homosexuality, Male | 1 | 2009 | 1240 | 0.010 |
Why?
|
Transformation, Bacterial | 1 | 2001 | 78 | 0.010 |
Why?
|
Virginia | 1 | 2001 | 121 | 0.010 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2003 | 272 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
New England | 1 | 2004 | 1022 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14722 | 0.010 |
Why?
|
Blood Cells | 1 | 2003 | 309 | 0.010 |
Why?
|
Pregnancy | 2 | 2013 | 29144 | 0.010 |
Why?
|
Ampicillin Resistance | 1 | 2000 | 11 | 0.010 |
Why?
|
Sequence Analysis | 1 | 2000 | 256 | 0.010 |
Why?
|
Health Care Costs | 1 | 2013 | 3209 | 0.010 |
Why?
|
Signal Transduction | 1 | 2003 | 23403 | 0.010 |
Why?
|
Hydrolysis | 1 | 2000 | 682 | 0.010 |
Why?
|
Peritonitis | 1 | 2001 | 365 | 0.010 |
Why?
|
Hospitals, University | 1 | 2001 | 571 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
Virulence | 1 | 2002 | 1333 | 0.010 |
Why?
|
Endocarditis, Bacterial | 1 | 2002 | 455 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2971 | 0.010 |
Why?
|
Drug Utilization | 1 | 2004 | 1183 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2003 | 2124 | 0.010 |
Why?
|
Long-Term Care | 1 | 2001 | 607 | 0.010 |
Why?
|
Catheterization | 1 | 2003 | 1470 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4751 | 0.010 |
Why?
|
Drug Interactions | 1 | 2001 | 1460 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1955 | 111 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1224 | 0.010 |
Why?
|
Feces | 1 | 2001 | 1401 | 0.010 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2003 | 1381 | 0.010 |
Why?
|
Hepatitis A | 1 | 1955 | 133 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15076 | 0.010 |
Why?
|
Hepatitis | 1 | 1955 | 227 | 0.010 |
Why?
|
Cortisone | 1 | 1953 | 89 | 0.010 |
Why?
|
Usher Syndromes | 1 | 1953 | 50 | 0.010 |
Why?
|
Phylogeny | 1 | 2000 | 2803 | 0.010 |
Why?
|
Pemphigus | 1 | 1953 | 103 | 0.010 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1953 | 648 | 0.010 |
Why?
|
Central Venous Pressure | 1 | 1971 | 78 | 0.010 |
Why?
|
Odds Ratio | 1 | 2004 | 9849 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 25625 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3420 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2000 | 6365 | 0.010 |
Why?
|
Methods | 1 | 1971 | 1129 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1955 | 636 | 0.010 |
Why?
|
Cell Cycle | 1 | 1997 | 2967 | 0.010 |
Why?
|
Comorbidity | 1 | 2004 | 10388 | 0.010 |
Why?
|
Dogs | 2 | 1971 | 3912 | 0.010 |
Why?
|
Population Surveillance | 1 | 1999 | 2616 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2001 | 5021 | 0.000 |
Why?
|
Models, Theoretical | 1 | 2000 | 3589 | 0.000 |
Why?
|
Regional Blood Flow | 1 | 1971 | 1525 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1971 | 1423 | 0.000 |
Why?
|
Carotid Arteries | 1 | 1971 | 952 | 0.000 |
Why?
|
Sex Factors | 1 | 2000 | 10397 | 0.000 |
Why?
|
Phenytoin | 1 | 1965 | 197 | 0.000 |
Why?
|
Coronary Vessels | 2 | 1971 | 3107 | 0.000 |
Why?
|
Digoxin | 1 | 1965 | 250 | 0.000 |
Why?
|
Adolescent | 2 | 2004 | 85781 | 0.000 |
Why?
|
Animals | 4 | 2002 | 168757 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 2 | 1965 | 2268 | 0.000 |
Why?
|
Prevalence | 1 | 1999 | 15226 | 0.000 |
Why?
|
Hemodynamics | 1 | 1971 | 4199 | 0.000 |
Why?
|
Heart Rate | 1 | 1971 | 4091 | 0.000 |
Why?
|
Infant | 1 | 2001 | 35136 | 0.000 |
Why?
|
Child, Preschool | 1 | 2001 | 41006 | 0.000 |
Why?
|
Electrocardiography | 1 | 1971 | 6442 | 0.000 |
Why?
|
Kidney | 1 | 1971 | 7186 | 0.000 |
Why?
|
Blood Pressure | 1 | 1971 | 8554 | 0.000 |
Why?
|
Coronary Circulation | 1 | 1959 | 1572 | 0.000 |
Why?
|
Child | 1 | 2001 | 77709 | 0.000 |
Why?
|